EUVIMEDEUVIMED entdecken
Crossref

Inhibitory effect of silver oxide nanoparticles and Saccharomyces cerevisiae on Escherichia coli and Staphylococcus aureus bacteria

Mais Qasem Mohammed, Ahmed Hamed Mahde Shugran

Experimental and Theoretical NANOTECHNOLOGY · 2026

DOI: 10.56053/10.1.13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Theoretical NANOTECHNOLOGY, 2026. Verfasst von Mais Qasem Mohammed und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Baker's yeast, or Saccharomyces cerevisiae, is a unicellular fungus that has been extensively studied and used as a suitable biofactory for the production of bio nanoparticles. The study aims to investigate the inhibitory effect of silver oxide nanoparticles on pathogenic bacteria. This study examines the biosynthesis, characterization, and antibacterial efficacy of silver oxide nanoparticles (AgO-NPs) that are synthesized from Saccharomyces cerevisiae extract. Pathogenic bacteria, specifically Staphylococcus aureus and Escherichia coli, are isolated and identified from diarrhoea samples and utilized as test organisms. Phytase enzyme is isolated from both commercial and locally sourced S. cerevisiae yeast using solvent extraction and precipitation techniques. The isolated enzyme functioned as a biocatalyst in the eco-friendly creation of AgO nanoparticles. Silver oxide is reduced and stabilized using the enzymatic extract, resulting in nanoparticles that are later characterized by FTIR, UV–vis spectroscopy, and scanning electron microscopy (SEM). FTIR examination verified the existence of functional groups, including hydroxyl, carbonyl, and amine groups, signifying the participation of proteins, phenols, and polysaccharides in the stabilization of nanoparticles. The UV–vis spectra exhibited a large absorption peak at 400–430 nm, indicative of surface plasmon resonance (SPR) in silver nanoparticles, whereas SEM micrographs displayed spherical, agglomerated nanoparticles with an average diameter of 53 nm. The antibacterial activity is evaluated using the well-diffusion method against Staphylococcus aureus and Escherichia coli. The AgO-NPs demonstrate concentrationdependent inhibition, achieving maximum inhibition zones of 15 mm and 16 mm, respectively, at 100 mg/dl. The results indicate the promise of yeast-derived silver oxide nanoparticles as environmentally sustainable and efficient antibacterial agents against pathogenic microorganisms.

Zitieren

APA

Mohammed, M. Q., & Shugran, A. H. M. (2026). Inhibitory effect of silver oxide nanoparticles and Saccharomyces cerevisiae on Escherichia coli and Staphylococcus aureus bacteria. Experimental and Theoretical NANOTECHNOLOGY. https://doi.org/10.56053/10.1.13

Vancouver

Mohammed MQ, Shugran AHM. Inhibitory effect of silver oxide nanoparticles and Saccharomyces cerevisiae on Escherichia coli and Staphylococcus aureus bacteria. Experimental and Theoretical NANOTECHNOLOGY. 2026. doi:10.56053/10.1.13

BibTeX
@article{Mohammed2026,
  author = {Mohammed, Mais Qasem and Shugran, Ahmed Hamed Mahde},
  title = {Inhibitory effect of silver oxide nanoparticles and Saccharomyces cerevisiae on Escherichia coli and Staphylococcus aureus bacteria},
  journal = {Experimental and Theoretical NANOTECHNOLOGY},
  year = {2026},
  doi = {10.56053/10.1.13}
}
Kostenlos starten →